The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
Condition(s):Laparoscopic MyomectomyLast Updated:May 2, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Laparoscopic MyomectomyLast Updated:May 2, 2022Recruiting
Condition(s):MyomaLast Updated:May 2, 2022Recruiting
Condition(s):MyomaLast Updated:February 16, 2022Recruiting
Condition(s):Cirrhosis; Ascites HepaticLast Updated:July 13, 2021Completed
Condition(s):Terlipressin Adverse ReactionLast Updated:July 22, 2019Unknown status
Condition(s):Terlipressin Adverse Reaction; Ascites Hepatic; Liver Failure; Acute Kidney InjuryLast Updated:January 9, 2020Unknown status
Condition(s):Hepatectomy, Surgical Blood Loss, TerlipressinLast Updated:December 27, 2017Completed
Condition(s):Liver Cirrhosis; Portal Hypertension; Variceal Hemorrhage; Bleeding; Esophageal and Gastric VaricesLast Updated:February 24, 2023Not yet recruiting
Condition(s):Hemodynamics, Liver, TerlipressinLast Updated:December 19, 2017Completed
Condition(s):Septic ShockLast Updated:October 15, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.